oldid38956

Antibiotice sees slight growth

Drugmaker Antibiotice Iasi has met the targets for 2003: only slight turnover and profit growth, as stronger financial stability was favoured. The company yesterday reported preliminary sales worth $36m (1,215bn ROL), up 5% from 2002. But, in real terms, sales...